These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 3336989)

  • 1. Sustained therapeutic efficacy and safety of oral propafenone for treatment of chronic ventricular arrhythmias: a 2-year experience.
    Dinh H; Baker BJ; de Soyza N; Murphy ML
    Am Heart J; 1988 Jan; 115(1 Pt 1):92-6. PubMed ID: 3336989
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of propafenone in patients with stable ventricular arrhythmias.
    de Soyza N; Terry L; Murphy ML; Thompson CH; Doherty JE; Sakhaii M; Dinh H
    Am Heart J; 1984 Aug; 108(2):285-9. PubMed ID: 6380253
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy of propafenone compared with quinidine in chronic ventricular arrhythmias.
    Dinh HA; Murphy ML; Baker BJ; deSoyza N; Franciosa JA
    Am J Cardiol; 1985 Jun; 55(13 Pt 1):1520-4. PubMed ID: 3890510
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antiarrhythmic efficacy and tolerance of oral propafenone in patients with frequent ventricular arrhythmias: experience of a multicentre study.
    Geibel A; Meinertz T; Zehender M; Vitak J; Hohnloser S; Kunz-Fritze A; Just H
    Eur Heart J; 1989 Sep; 10 Suppl E():81-7. PubMed ID: 2680506
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical experience with propafenone for cardiac arrhythmias in the young.
    Heusch A; Kramer HH; Krogmann ON; Rammos S; Bourgeous M
    Eur Heart J; 1994 Aug; 15(8):1050-6. PubMed ID: 7527342
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Amiodarone and propafenone: evaluation using serial Holter recordings in patients with ventricular arrhythmia].
    Ventosa A; Adragão P; Bonhorst D; Seabra-Gomes R
    Rev Port Cardiol; 1990 Jan; 9(1):33-9. PubMed ID: 1691653
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Propafenone. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic use in the treatment of arrhythmias.
    Harron DW; Brogden RN
    Drugs; 1987 Dec; 34(6):617-47. PubMed ID: 3322781
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Short- and long-term effects of propafenone in ventricular arrhythmias.
    Gaita F; Richiardi E; Bocchiardo M; Asteggiano R; Pinnavaia A; Di Leo M; Rosettani E; Brusca A
    Int J Cardiol; 1986 Nov; 13(2):163-70. PubMed ID: 3793276
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Propafenone for refractory ventricular arrhythmias: correlation with drug plasma levels during long-term treatment.
    Naccarella F; Bracchetti D; Palmieri M; Marchesini B; Ambrosioni E
    Am J Cardiol; 1984 Nov; 54(8):1008-14. PubMed ID: 6496321
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The use of associated propafenone in patients with amiodarone-resistant ventricular tachycardia.
    Morgera T; Dreas L; Humar F; Maras P; Chersevani D; Camerini F
    Int J Cardiol; 1991 May; 31(2):187-97. PubMed ID: 1869328
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Short-term and long-term treatment with propafenone: determinants of arrhythmia suppression, persistence of efficacy, arrhythmogenesis, and side effects in patients with symptoms.
    Zehender M; Hohnloser S; Geibel A; Furtwängler A; Olschewski M; Meinertz T; Just H
    Br Heart J; 1992 Jun; 67(6):491-7. PubMed ID: 1622701
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of propafenone on ventricular arrhythmias: double-blind, parallel, randomized, placebo-controlled dose-ranging study.
    Singh BN; Kaplinsky E; Kirsten E; Guerrero J
    Am Heart J; 1988 Dec; 116(6 Pt 1):1542-51. PubMed ID: 3057844
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Propafenone in the treatment of patients with malignant ventricular tachyarrhythmias.
    Kowey PR; Stohler JL; Friehling TD; Marinchak RA
    Can J Cardiol; 1991 May; 7(4):175-80. PubMed ID: 2070286
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Propafenone. A reappraisal of its pharmacology, pharmacokinetics and therapeutic use in cardiac arrhythmias.
    Bryson HM; Palmer KJ; Langtry HD; Fitton A
    Drugs; 1993 Jan; 45(1):85-130. PubMed ID: 7680987
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Diprafenone--comparative study of anti-arrhythmia therapy with propafenone].
    Geibel A; Zehender M; Hohnloser S; Landsrath C; Meinertz T; Just H
    Z Kardiol; 1988 Jul; 77(7):464-9. PubMed ID: 2463720
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oral propafenone therapy for children with arrhythmias: efficacy and adverse effects in midterm follow-up.
    Guccione P; Drago F; Di Donato RM; Cicini MP; Pasquini L; Marino B; Marcelletti C; Ragonese P
    Am Heart J; 1991 Oct; 122(4 Pt 1):1022-7. PubMed ID: 1927853
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Double-blind placebo-controlled evaluation of propafenone in suppressing ventricular ectopic activity.
    Hodges M; Salerno D; Granrud G
    Am J Cardiol; 1984 Nov; 54(9):45D-50D. PubMed ID: 6388303
    [TBL] [Abstract][Full Text] [Related]  

  • 18. European experience with the antiarrhythmic efficacy of propafenone for supraventricular and ventricular arrhythmias.
    Coumel P; Leclercq JF; Assayag P
    Am J Cardiol; 1984 Nov; 54(9):60D-66D. PubMed ID: 6208770
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy of oral propafenone in chronic ventricular arrhythmias: a placebo controlled cross-over exercise study.
    Härtel G
    Eur Heart J; 1985 Feb; 6(2):123-9. PubMed ID: 3891347
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Propafenone for the treatment of refractory complex ventricular ectopic activity.
    Hammill SC; Sorenson PB; Wood DL; Sugrue DD; Osborn MJ; Gersh BJ; Holmes DR
    Mayo Clin Proc; 1986 Feb; 61(2):98-103. PubMed ID: 3945115
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.